News
PRFX
0.8894
-6.45%
-0.0613
Weekly Report: what happened at PRFX last week (1208-1212)?
Weekly Report · 3d ago
PainReform’s LayerBio Platform Advances with Multi-Drug Capability
TipRanks · 12/10 13:59
PainReform completed R&D assessment of LayerBio’s drug-delivery platform
TipRanks · 12/10 13:50
PainReform Confirms LayerBio Ocular Platform Can Deliver Multiple Drugs in Sustained-Release Form
Reuters · 12/10 13:30
Weekly Report: what happened at PRFX last week (1201-1205)?
Weekly Report · 12/08 09:18
PainReform Initiates Phase II Development for OcuRing™-K
TipRanks · 12/02 14:58
PainReform Launches Phase II Trial Development for OcuRing-K Drop-Less Ocular Therapy
Reuters · 12/02 14:40
PainReform commences development plan for OcuRing-K Phase II trial
TipRanks · 12/02 14:25
PainReform Commences Development Plan For OcuRing-K, LayerBio's Patented, Drop-Less, Intraoperatively Administered Sustained-Release Ocular Therapy
Benzinga · 12/02 14:20
BRIEF-Painreform Commences Development For Ocuring™-K Phase II Trial
Reuters · 12/02 14:19
PainReform Advances Drop-Less OcuRing-K Therapy Toward Phase II Trial
Reuters · 12/02 14:15
PainReform Commences Development for OcuRing™-K Phase II Trial, LayerBio’s Drop-Less Sustained-Release Ocular Therapy
Barchart · 12/02 08:15
Weekly Report: what happened at PRFX last week (1124-1128)?
Weekly Report · 12/01 09:17
PainReform Ltd. Announces December 2025 Shareholders Meeting with Key Proposals
TipRanks · 11/25 21:54
PainReform Ltd. Announces Date for Upcoming Annual General Meeting of Shareholders
Reuters · 11/25 21:16
Weekly Report: what happened at PRFX last week (1117-1121)?
Weekly Report · 11/24 09:18
Weekly Report: what happened at PRFX last week (1110-1114)?
Weekly Report · 11/17 09:18
PainReform’s DeepSolar Advances AI Reporting Engine for Solar Assets
TipRanks · 11/12 14:34
PainReform’s DeepSolar advances development of AI-driven reporting engine
TipRanks · 11/12 14:10
DeepSolar Advances AI-Driven Reporting Engine for Solar Asset Analysis
Reuters · 11/12 14:00
More
Webull provides a variety of real-time PRFX stock news. You can receive the latest news about Painreform Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PRFX
PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.